Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan.

Malaria journal - 15 Jul 2007

Mukhtar Ebtihal A, Gadalla Nahla B, El-Zaki Salah-Eldin G, Mukhtar Izdihar, Mansour Fathi A, Babiker Ahmed, El-Sayed Badria B

Abstract excerpt

BACKGROUND: A combination of artesunate (AS) plus sulphadoxine/pyrimethamine (SP) as first-line and artemether-lumefantrine (AL) as second-line treatment are currently recommended against uncomplicated P. falciparum infection in Sudan. However, there is limited information on the efficacy of ACTs in the country and only one report of PCR-corrected results for AS/SP only. METHODS: The WHO protocol for the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Artesunate
Share to Ethanolamines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorenes

Share to Merozoite Surface Protein 1

Share to Pyrimethamine

Share to Sesquiterpenes

Share to Sulfadoxine

Source

Open in PubMed Open full text

Identifiers

PMID: 17631681
DOI: 10.1186/1475-2875-6-92
PMCID: PMC1940006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan.PMID 17631681Read ↗

High efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.Semantic proximity Read ↗

Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern SudanSemantic proximity Read ↗

Efficacy of sulfadoxin pyrimethamine for uncomplicated Plasmodium falciparum malaria in a small sample of Sudanese children.Semantic proximity Read ↗

Efficacies of mefloquine alone and of artesunate followed by mefloquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.Semantic proximity Read ↗

Sulphadoxine/pyrimethamine versus amodiaquine for treating uncomplicated childhood malaria in Gabon: a randomized trial to guide national policy.Semantic proximity Read ↗

Plasmodium falciparum population structure in Sudan post artemisinin-based combination therapy.Semantic proximity Read ↗

Frequency distribution of antimalarial drug resistance alleles among Plasmodium falciparum isolates from Gezira State, central Sudan, and Gedarif State, eastern Sudan.Semantic proximity Read ↗

High Prevalence of Artemisinin-Resistant Plasmodium falciparum, Southeastern SudanSemantic proximity Read ↗

Clinical efficacy of artemisinin-lumefantrine and status of antifolate drug resistance markers in western KenyaSemantic proximity Read ↗

Molecular assessment of drug resistance in Plasmodium falciparum from Bahr El Gazal province, Sudan.Semantic proximity Read ↗

Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast, West Africa.Semantic proximity Read ↗

High frequency of Plasmodium falciparum CICNI/SGEAA and CVIET haplotypes without association with resistance to sulfadoxine/pyrimethamine and chloroquine combination in the Daraweesh area, in Sudan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.